Financial

News

GBL joins CVC in €10.7bn takeover bid for Recordati

A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.

News

Manufacturing hangover drives Daiichi Sankyo into the red

Long-term third-party manufacturing contracts and a slower-than-expected rollout of its cancer ADCs have driven Daiichi Sankyo into a net loss.

News

Novo Nordisk's chief executive, Mike Doustdar

Novo Nordisk buoyed by outperforming oral Wegovy in Q1

Shares in Novo Nordisk rose this morning after its highly anticipated first-quarter results revealed better-than-expected uptake of oral Wegovy.

News

Stéphane Bancel, Moderna's chief executive.

Moderna's Q1 revenues rocket, thanks to ex-US sales

Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.

News

GLP-1s drive Lilly's Q1, but it's reticent on oral launch

Investors are itching for news on the rollout of Lilly's oral weight-loss drug Foundayo, but there's little information in its first-quarter update.

News

AZ will invest £300m in UK, says PM Keir Starmer

AstraZeneca has delivered a much-needed boost to the UK government alongside a strong set of first-quarter results.

GBL joins CVC in €10.7bn takeover bid for Recordati

Manufacturing hangover drives Daiichi Sankyo into the red

Novo Nordisk buoyed by outperforming oral Wegovy in Q1

Moderna's Q1 revenues rocket, thanks to ex-US sales

GLP-1s drive Lilly's Q1, but it's reticent on oral launch

AZ will invest £300m in UK, says PM Keir Starmer

ASCO 2026: Chinese firms take a front seat in oncology, with...

Discover a new era of healthcare panel engagement: Grounded ...

Financial

Editor's Picks